Amyris Stock Price Prediction 2025, 2026, 2030, 2050, 2060

Amyris Stock Price Prediction: 2025, 2026, 2030, 2050, 2060 Outlook – Amyris Inc. (NASDAQ: AMRS) is a biotechnology company. It focuses on sustainable ingredients and clean chemistry. The company uses synthetic biology to produce alternatives to traditional products. Investors are keen on its long-term potential.

This article provides a detailed stock price prediction for Amyris. We cover short-term and long-term forecasts. The analysis includes 2025, 2026, 2030, 2050, and 2060.

Current Status of Amyris Stock

As of August 2025, Amyris trades at approximately $0.05 . The stock has shown high volatility. It has a Fear & Greed Index score of 39, indicating bearish sentiment .

Key metrics:

  • 50-Day SMA: $0.86
  • 200-Day SMA: $1.27
  • 14-Day RSI: 31.62 (Oversold)

The company faces financial challenges. It reported negative earnings per share (EPS) of -$1.43 . Revenue growth remains uncertain.

Amyris Stock Price Prediction for 2025

Short-Term Forecast (Next 3-6 Months)

  • 1-Month Prediction: $0.049963 (-0.07% change)
  • 3-Month Prediction: $0.049871
  • 6-Month Prediction: Unavailable (locked behind paywall)

Analysts expect minor fluctuations. The stock may trade between $0.049766 and $0.050087 in 2025 .

Monthly Breakdown (2025)

MonthMin. PriceAvg. PriceMax. PricePotential ROI
August$0.049766$0.050$0.0500870.02%
September$0.05$0.051$0.0590.17%
October$0.06$0.068$0.070.18%
November$0.06$0.069$0.07-0.45%
December$0.07$0.072$0.080.23%

Key Takeaway:
Amyris may see slight growth in late 2025. However, risks remain high.

Amyris Stock Price Prediction for 2026

Annual Outlook

  • Average Price: $0.02
  • High Estimate: $0.02
  • Low Estimate: $0.02

Monthly Predictions (2026)

MonthPrice TargetChange
January$0.0162+6.43%
February$0.0170+4.93%
March$0.0176+3.84%
December$0.0193-0.82%

Analysis:
2026 could show moderate growth. The stock may stabilize if financials improve.

Long-Term Forecast: 2030, 2050, 2060

2030 Prediction

  • Average Price: $0.03
  • High Estimate: $0.04
  • Potential ROI: +381% from 2025 levels

Key Drivers:

  • Expansion in sustainable products.
  • Government support for clean energy.

2050 and Beyond

No concrete data exists for 2050 or 2060. However, if Amyris survives:

  • Bull Case: $5-$10 (if it becomes a market leader).
  • Bear Case: Delisting or bankruptcy.

Risks and Challenges

  1. Financial Instability:
  • Negative EPS (-$1.43) .
  • High debt ($1.03 billion) .
  1. Market Sentiment:
  • Bearish outlook (Fear Index: 39) .
  1. Competition:
  • Rivals in synthetic biology sector.

Should You Invest in Amyris?

Pros:

  • Potential in sustainable chemistry.
  • Long-term growth if financials stabilize.

Cons:

  • High risk of further decline.
  • Negative cash flows (-$540M in 2025) .

Final Verdict:
Only invest if you accept high risk. Diversify your portfolio.

Conclusion

Amyris stock is highly speculative. Short-term forecasts suggest minor movements. Long-term predictions are uncertain. Investors must monitor financial health closely.

For updates, check reliable stock analysis platforms.


Read More

Leave a Comment